Mass General Brigham

Dr. Chan Raut Explains How Sub-Specialized Experts Work Together to Care for Patients with Cancer

Dr. Chan Raut outlines how Mashon & Brigham leverages a dense network of sub‑specialized oncologists to deliver personalized cancer care. The institution’s hallmark is its ability to match any patient’s disease profile with experts across surgery, radiation, medical oncology, pathology and genetics, creating a seamless continuum of treatment. The discussion emphasizes that rare and highly complex cancers benefit most from this multidisciplinary approach, where clinicians convene regularly to review cases, integrate the latest trial data, and co‑author research that directly informs therapeutic choices. By embedding research within clinical workflows, the center ensures that patient care reflects cutting‑edge evidence rather than static protocols. Raut punctuates his remarks with memorable lines: “One team saves more lives every year,” and “We are one against cancer,” underscoring a culture that prizes collective responsibility over individual accolades. He cites concrete examples where joint tumor boards have identified novel combination therapies, accelerating enrollment in pioneering studies. The model’s implications extend beyond patient outcomes; it establishes a replicable blueprint for academic health systems seeking to harmonize research and practice. As oncology becomes increasingly molecular and individualized, institutions that institutionalize teamwork are poised to set new standards, attract top talent, and secure funding for innovative trials.